324 related articles for article (PubMed ID: 34321959)
1. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Liu S; Cai Y; Changyong E; Sheng J; Zhang X
Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
[TBL] [Abstract][Full Text] [Related]
2. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
3. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
5. Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis.
Ding W; Wang Y; Ma Y; Lin L; Li M
Dis Markers; 2022; 2022():3839480. PubMed ID: 36061357
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
10. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
Ma C; Cui Z; Wang Y; Zhang L; Wen J; Guo H; Li N; Zhang W
Bosn J Basic Med Sci; 2021 Feb; 21(1):47-60. PubMed ID: 33188589
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
Zheng X; Liu X; Zheng H; Wang H; Hong D
Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
16.
Deng Y; Ma H; Hao J; Xie Q; Zhao R
Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
[TBL] [Abstract][Full Text] [Related]
17. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
Xu JS; Liao KL; Wang X; He J; Wang XZ
J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
19.
Ye H; Li T; Wang H; Wu J; Yi C; Shi J; Wang P; Song C; Dai L; Jiang G; Huang Y; Yu Y; Li J
Front Immunol; 2021; 12():649551. PubMed ID: 33815409
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]